Compare VERA & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | AAMI |
|---|---|---|
| Founded | 2016 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2021 | N/A |
| Metric | VERA | AAMI |
|---|---|---|
| Price | $50.27 | $47.32 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $67.67 | $43.50 |
| AVG Volume (30 Days) | ★ 1.8M | 231.8K |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.08% |
| EPS Growth | N/A | ★ 45.00 |
| EPS | N/A | ★ 2.40 |
| Revenue | N/A | ★ $559,300,000.00 |
| Revenue This Year | N/A | $17.88 |
| Revenue Next Year | N/A | $21.58 |
| P/E Ratio | ★ N/A | $19.89 |
| Revenue Growth | N/A | ★ 19.25 |
| 52 Week Low | $18.53 | $22.60 |
| 52 Week High | $50.16 | $54.99 |
| Indicator | VERA | AAMI |
|---|---|---|
| Relative Strength Index (RSI) | 83.77 | 56.57 |
| Support Level | $40.38 | $45.67 |
| Resistance Level | $47.10 | $49.38 |
| Average True Range (ATR) | 3.45 | 1.56 |
| MACD | 1.32 | 0.44 |
| Stochastic Oscillator | 95.46 | 67.05 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.